Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPCNCT01995058ExelixisPhase 2Terminated2014-11Actual
Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma ParticipantsNCT02004028VSTMPhase 2Terminated2019-06-19Actual
Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic DermatitisNCT02004041Vanda PharmaceuticalsPhase 2Completed2015-02-19Actual
Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With GlioblastomaNCT02014844IBRXPhase 2Completed2016-12Actual
Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALSNCT02017912Brainstorm-Cell TherapeuticsPhase 2Completed2016-03Actual
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's SarcomaNCT02029430IBRXPhase 2Completed2016-04-25Actual
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart FailureNCT02032004Mesoblast, Inc.Phase 3Completed2020-01-30Actual
Phase 3 Study to Treat Patients With Soft Tissue SarcomasNCT02049905IBRXPhase 3Completed2017-05Actual
Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic CholestasisNCT02057718MIRMPhase 2Completed2020-05-08Actual
A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) InfectionNCT02065336Arrowhead PharmaceuticalsPhase 2Terminated2017-01Actual
Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis ParticipantsNCT02065700LKFTPhase 2Completed2023-01-19Actual
Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)NCT02077192Rigel PharmaceuticalsPhase 3Completed2020-06-02Actual
Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)NCT02112656ImunonPhase 3Completed2020-04-27Actual
Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary HyperhidrosisNCT02129660Journey Medical CorporationPhase 2Completed2015-01Actual
Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic PruritusNCT02143648Trevi TherapeuticsPhase 2, Phase 3Completed2015-07Actual
Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic PruritusNCT02143973Trevi TherapeuticsPhase 2, Phase 3Completed2016-01Actual
A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal BurnsNCT02148705MDWDPhase 3Completed2018-06-12Actual
Study of Nalbuphine HCl ER Tablets in Patients With Prurigo NodularisNCT02174419Trevi TherapeuticsPhase 2, Phase 3Completed2016-08Actual
Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo NodularisNCT02174432Trevi TherapeuticsPhase 2, Phase 3Completed2017-09-03Actual
Extension Study Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)NCT02175004IONSPhase 3Completed2020-09-11Actual
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung CancerNCT02200757IBRXPhase 2Completed2017-05-15Actual
Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin StudiesNCT02214160RAREPhase 2Completed2020-12-03Actual
Safety and Efficacy Study of OMS721 in Patients With Thrombotic MicroangiopathiesNCT02222545Omeros CorporationPhase 2Completed2020-01-30Actual
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)NCT02227251KPTIPhase 2Active not recruiting2026-12Estimated
A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar CarcinomaNCT02234986CASI pharmaceuticals, Inc.Phase 2Completed2018-06-30Actual
Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive CandidiasisNCT02244606SCYXPhase 2Completed2016-06Actual
Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.NCT02264288Celularity IncorporatedPhase 2Terminated2018-02-27Actual
Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related ConditionsNCT02277704Tonix Pharmaceuticals, Inc.Phase 2Completed2016-05Actual
A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of CareNCT02278718MDWDPhase 3Completed2021-04Actual
Evaluate SAGE-547 in Female Participants With Severe Postpartum DepressionNCT02285504SUPNPhase 2Completed2015-06-05Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.